Continue
By using our website you accept our cookies policy.Find out more

Biomedical catalyst 2017 round 3: early stage

Registration is closed
Funding details
Registration opens
31 Jul 2017, 00:00
Closes
11 Oct 2017, 12:00
Award
£10 million
Organisation
The Biomedical Catalyst is a partnership between Innovate UK and the Medical Research Council (MRC)
Support phone number
0300 321 4357
Summary

Micro, small or medium-size UK companies can apply for a share of £10 million to work alone or with others on solving healthcare challenges.

The aim of this competition is to support the development of technologies and processes including:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

The biomedical catalyst has 4 types of funding award designed to support small to medium enterprises (SMEs) that are developing a product or process. It helps them progress from initial concept through to late-stage development.

Each type of award has a different scope and you should apply only if your project fits a specific competition scope.

This is an early-stage competition. They are looking to fund projects that enable SMEs to complete a data package sufficient to support the subsequent testing of their product or process in a clinical setting (or other relevant environment). The early-stage project can include:

  • experimental evaluation (lab scale)
  • use of in vitro and in vivo models (but not studies in humans or patients) to evaluate proof of concept and safety testing to appropriate regulatory standards
  • exploration of potential production mechanisms
  • early-stage prototyping
  • product development planning
  • intellectual property protection

Projects should last between one and 3 years and range between £250,000 and £4 million.

Find out more on the competition page here.

Related Funding Opportunities

Horizon 2020: JTI-IMI2-2015-08-SINGLE-STAGE (H2020-JTI-IMI2-2015-08-SINGLE-STAGE)

Businesses can apply for a share of €70m to capture emerging scientific advances and to progress those rapidly into health care intervention.
Opens:
18.12.15
Closes:
15.03.18

Horizon 2020: Security (H2020-SU-SEC-2018-2019-2020)

This Call deals with R&D and innovation towards establishing disaster-resilient societies, fighting against crime and terrorism.
Opens:
15.03.18
Closes:
23.08.18